Document is current
Any future updates will be listed below
-
Authors
Alrawashdh, Neda
Sweasy, Joann
Erstad, Brian
McBride, Ali
Persky, Daniel O.
Abraham, Ivo
- License Information
-
More Information
Article History
Received: 30 March 2021
Accepted: 4 July 2021
First Online: 19 July 2021
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: McBride serves on Speakers Bureaus for Coherus BioSciences and Merck. He is now at Bristol Myers Squibb in a position unrelated to this study. Abraham is the joint equity owner in Matrix45. By company policy, owners and employees are prohibited from owning equity in client and sponsor organizations (except through mutual funds or other independently administered collective investment instruments), contracting independently with client and sponsor organizations or receiving compensation independently from such organizations. Matrix45 provides similar services to other biopharmaceutical, diagnostics, and medical device companies on a nonexclusivity basis. Of relevance to this paper, Matrix45 has not provided any services to this study. Abraham is the quantitative method editor of <i>JAMA Dermatology</i> and deputy editor-in-chief of the <i>Journal of Medical Economics</i>. The remaining authors have no relevant financial or nonfinancial interests to disclose.
